Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 1996 Oct;47(4):1085-7.

Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.

Author information

1
Graduate School of Neurosciences Amstordam, The Netherlands.

Abstract

We studied the effect of olanzapine (1 to 15 mg/d) in 15 nondemented parkinsonian patients with drug-induced psychosis. Psychotic symptoms decreased significantly during treatment, and there was no worsening of extrapyramidal symptoms. These results suggest that olanzapine is a well-tolerated and effective treatment for drug-induced psychosis in nondemented patients with Parkinson's disease.

PMID:
8857751
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center